{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:41:04Z","timestamp":1786653664114,"version":"build-2736575974"},"reference-count":21,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,7,8]]},"DOI":"10.2967\/jnumed.126.272472","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:39Z","timestamp":1786650039000},"page":"jnumed.126.272472","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Trial Protocol for LPS-Boost: Intensified [\n                    <sup>177<\/sup>\n                    Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA\u2013Expressing Disease"],"prefix":"10.2967","author":[{"given":"Amir","family":"Iravani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Miyaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Castellanos","family":"Reiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine L.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Nega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngho","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Flavell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin C.","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Nadal Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajitha","family":"Sunkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Yezefski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Grivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather H.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan Y.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Czernin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremie","family":"Calais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"2026081312400927000_jnumed.126.272472v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00950-8"},{"key":"2026081312400927000_jnumed.126.272472v1.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322"},{"key":"2026081312400927000_jnumed.126.272472v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01653-2"},{"key":"2026081312400927000_jnumed.126.272472v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00605-2"},{"key":"2026081312400927000_jnumed.126.272472v1.5","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.233460"},{"key":"2026081312400927000_jnumed.126.272472v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00237-3"},{"key":"2026081312400927000_jnumed.126.272472v1.7","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.178483"},{"key":"2026081312400927000_jnumed.126.272472v1.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264953"},{"key":"2026081312400927000_jnumed.126.272472v1.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2702"},{"key":"2026081312400927000_jnumed.126.272472v1.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268167"},{"key":"2026081312400927000_jnumed.126.272472v1.11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/pst.1654","article-title":"Sample size calculation for the one-sample log-rank test","volume":"14","author":"Wu","year":"2015","journal-title":"Pharm Stat."},{"key":"2026081312400927000_jnumed.126.272472v1.12","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1007\/s00259-025-07313-z","article-title":"Organ and tumour dosimetry of 177Lu-rhPSMA-10.1, a novel PSMA-targeted therapy: results from a phase I trial","volume":"52","author":"Nagarajah","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026081312400927000_jnumed.126.272472v1.13","doi-asserted-by":"crossref","first-page":"S999","DOI":"10.1016\/j.annonc.2024.08.1739","article-title":"The STAMPEDE2 177Lutetium-PSMA-617 (177Lu-PSMA-617) trial: a phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) starting androgen deprivation therapy (ADT) [abstract]","volume":"35(suppl 2)","author":"Padden-Modi","year":"2024","journal-title":"Ann Oncol."},{"key":"2026081312400927000_jnumed.126.272472v1.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261906"},{"key":"2026081312400927000_jnumed.126.272472v1.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.270916"},{"key":"2026081312400927000_jnumed.126.272472v1.16","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1158\/1078-0432.CCR-21-4531","article-title":"Prostate-specific membrane antigen expression and response to DNA damaging agents in prostate cancer","volume":"28","author":"Sheehan","year":"2022","journal-title":"Clin Cancer Res."},{"key":"2026081312400927000_jnumed.126.272472v1.17","doi-asserted-by":"publisher","DOI":"10.1002\/stem.318"},{"key":"2026081312400927000_jnumed.126.272472v1.18","first-page":"1483","article-title":"Cellular aging and senescence in cancer: a holistic review of cellular fate determinants","volume":"16","author":"Tufail","year":"2024","journal-title":"Aging Dis."},{"key":"2026081312400927000_jnumed.126.272472v1.19","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.7150\/thno.82101","article-title":"Imaging DNA damage response by gammaH2AX in\u00a0vivo predicts treatment response to lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcome","volume":"13","author":"O\u2019Neill","year":"2023","journal-title":"Theranostics."},{"key":"2026081312400927000_jnumed.126.272472v1.20","doi-asserted-by":"crossref","first-page":"122915","DOI":"10.1016\/j.biomaterials.2024.122915","article-title":"Targeting senescence with radioactive 223Ra\/Ba SAzymes enables senolytics-unlocked one-two punch strategy to boost anti-tumor immunotherapy","volume":"315","author":"Zhang","year":"2025","journal-title":"Biomaterials."},{"key":"2026081312400927000_jnumed.126.272472v1.21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2020.38.6_suppl.45","article-title":"Patient-reported outcomes (PRO) from a phase I\/II dose-escalation study of fractionated dose 177Lu-PSMA-617 for progressive metastatic castration-resistant prostate cancer (mCRPC) [abstract]","volume":"38","author":"Vlachostergios","year":"2020","journal-title":"J Clin Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.126.272472","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:41Z","timestamp":1786650041000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.126.272472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":21,"alternative-id":["10.2967\/jnumed.126.272472"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.126.272472","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]}}}